Country of origin · Republic of Korea
Elravie Re2O is a Korean MFDS-approved next-generation ECM skin booster built on micronised human acellular dermal matrix (hADM) — 150 mg per syringe. Rather than a filler, it replenishes the skin’s own extracellular matrix — collagen, elastin and structural proteins — to restore firmness, texture and hydration from within.
Why choose Elravie Re2O
How Elravie Re2O works
On injection the particulated hADM delivers a ready-made extracellular-matrix scaffold into the dermis, giving immediate structural support. As the matrix is gradually remodelled over the following weeks, it signals fibroblasts to build new collagen and elastin, improving firmness and skin quality over a treatment course.
Elravie Re2O specifications
Elravie Re2O common uses
- ·Overall skin firmness and elasticity
- ·Skin texture and enlarged pores
- ·Fine lines and early wrinkles
- ·Dermal hydration and skin quality
Contraindications
- ·Pregnancy and lactation
- ·Active infection, inflammation, or skin lesions at or near the treatment area
- ·Known hypersensitivity to any component of the product
- ·History of keloid or hypertrophic scarring
- ·Bleeding disorders or anticoagulant therapy without appropriate clearance
Elravie Re2O — frequently asked questions
Elravie Re2O is a Korean next-generation skin booster based on human acellular dermal matrix (hADM). Each syringe contains 150 mg of micronised hADM — real extracellular-matrix components (collagen, elastin, proteins) delivered into the dermis to improve skin quality.
hADM is donor-derived human dermal tissue that has been processed to remove all cells and immunogenic components, leaving a pure, acellular extracellular-matrix scaffold. In Elravie Re2O this matrix is micronised into fine particles for injection.
No. It is a biorevitalization / ECM booster aimed at skin firmness, texture and hydration, not a volumising filler for adding contour or projection.
A PN booster such as Rejuran signals the skin to regenerate, and an HA booster mainly hydrates. Elravie Re2O instead supplies ready-made extracellular-matrix building blocks (collagen, elastin, proteins) directly — a different, matrix-replenishing mechanism.
Elravie Re2O is approved by the Korean MFDS; it is not a US FDA-approved product. Human acellular dermal matrix as a material has a long history in surgical tissue reconstruction, but that is separate from this finished product’s regulatory status. Verify the product’s status in your jurisdiction before use.
Yes. It is supplied as a lyophilized powder and reconstituted before treatment. The specific dilution and preparation are determined by the treating physician according to their technique and treatment goal.
The tissue is purified to remove cellular and immunogenic components, leaving an acellular ECM scaffold intended to reduce immune reactivity. As with any injectable, practitioner assessment and appropriate patient consent remain essential.
Elravie Re2O is generally used as a short course of sessions spaced a few weeks apart, with the exact plan set by the treating practitioner based on the individual’s skin. Skin-quality improvement builds over and after the course.
Store as directed on the product packaging, away from direct sunlight, and do not freeze. Refer to the packaging for the printed expiry date.
Elravie Re2O is a professional injectable intended for licensed healthcare professionals trained in skin-booster and mesotherapy treatments, used in accordance with local regulations and the official instructions for use.

Reviews
There are no reviews yet.